These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30293950)

  • 1. The promising role of miR-296 in human cancer.
    Zhu L; Deng H; Hu J; Huang S; Xiong J; Deng J
    Pathol Res Pract; 2018 Dec; 214(12):1915-1922. PubMed ID: 30293950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment.
    Gao Y; Feng B; Han S; Zhang K; Chen J; Li C; Wang R; Chen L
    Cell Physiol Biochem; 2016; 38(2):427-48. PubMed ID: 26828359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-205 in cancer: an angel or a devil?
    Qin AY; Zhang XW; Liu L; Yu JP; Li H; Wang SZ; Ren XB; Cao S
    Eur J Cell Biol; 2013 Feb; 92(2):54-60. PubMed ID: 23279926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-edged sword role of miRNA-633 and miRNA-181 in human cancers.
    Gupta J; Suliman M; Ali R; Margiana R; Hjazi A; Alsaab HO; Qasim MT; Hussien BM; Ahmed M
    Pathol Res Pract; 2023 Aug; 248():154701. PubMed ID: 37542859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-452: a double-edged sword in multiple human cancers.
    Karimi Dermani F; Datta I; Gholamzadeh Khoei S
    Clin Transl Oncol; 2023 May; 25(5):1189-1206. PubMed ID: 36622551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Roles of miR-25 and its Targeted Genes in Development of Human Cancer.
    Caiazza C; Mallardo M
    Microrna; 2016; 5(2):113-119. PubMed ID: 27594089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNAs in endocrine cancer metastasis.
    Lima CR; Gomes CC; Santos MF
    Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging roles of the polycistronic miR-106b∼25 cluster in cancer - A comprehensive review.
    Mehlich D; Garbicz F; Włodarski PK
    Biomed Pharmacother; 2018 Nov; 107():1183-1195. PubMed ID: 30257332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
    Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
    Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bioinformatics approach for identification of miR-100 targets implicated in breast cancer.
    Shamsi R; Seifi-Alan M; Behmanesh A; Omrani MD; Mirfakhraie R; Ghafouri-Fard S
    Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):99-105. PubMed ID: 29096749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment.
    Gao Y; Feng B; Han S; Lu L; Chen Y; Chu X; Wang R; Chen L
    Cell Physiol Biochem; 2016; 39(6):2186-2202. PubMed ID: 27802440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-224: as a potential target for miR-based therapy of cancer.
    Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH
    Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functions and mechanisms of miR-186 in human cancer.
    Wang Z; Sha HH; Li HJ
    Biomed Pharmacother; 2019 Nov; 119():109428. PubMed ID: 31525641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.
    Wu Z; Li X; Cai X; Huang C; Zheng M
    Tumour Biol; 2016 Jun; 37(6):7939-50. PubMed ID: 26700673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative mechanisms of miR-34a regulation in cancer.
    Slabáková E; Culig Z; Remšík J; Souček K
    Cell Death Dis; 2017 Oct; 8(10):e3100. PubMed ID: 29022903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY; Teng SC; Cheng TH; Wu KJ
    Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.